HUM Humana Inc

  1. Stocks
  2. Healthcare
  3. NYSE: HUM

Price (delayed)

$441.1

Market cap

$52.98B

P/E Ratio

42.5

Dividend/share

$3.54

EPS

$10.38

Enterprise value

$58.86B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 37

Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make ...

Highlights
The revenue has increased by 22% year-on-year and by 6% since the previous quarter
HUM's debt is down by 12% since the previous quarter
HUM's price to earnings (P/E) is 86% higher than its 5-year quarterly average of 23.1 and 45% higher than its last 4 quarters average of 29.6
The quick ratio has decreased by 24% YoY and by 10% from the previous quarter
Sector: Healthcare
Industry: Healthcare Plans
Website: http://www.humana.com
Peers: CNC UNH CI MOH

Key stats

What are the main financial stats of HUM

HUM stock price

How has the Humana stock price performed over time
Intraday
-1.17%
1 week
7.12%
1 month
1.75%
1 year
83.42%
YTD
72.22%
QTD
15.6%

Financial performance

How have Humana's revenue and profit performed over time
Revenue
$154.19B
Gross profit
$20.06B
Operating income
$2.38B
Net income
$1.25B
Gross margin
13%
Net margin
0.8%
HUM's operating margin is down by 35% year-on-year and by 21% since the previous quarter
The revenue has increased by 22% year-on-year and by 6% since the previous quarter
The operating income has contracted by 20% YoY and by 12% from the previous quarter
HUM's net margin is down by 20% year-on-year and by 11% since the previous quarter

Price vs fundamentals

How does HUM's price correlate with its fundamentals

Growth

What is Humana's growth rate over time

Valuation

What is Humana stock price valuation
HUM P/E details
P/E
42.5
P/B
2.81
P/S
0.34
EV/EBIT
24.29
EV/EBITDA
18.48
EV/Sales
0.38
HUM's price to earnings (P/E) is 86% higher than its 5-year quarterly average of 23.1 and 45% higher than its last 4 quarters average of 29.6
The EPS has declined by 3% year-on-year and by 2.5% since the previous quarter
The price to book (P/B) is 50% higher than the last 4 quarters average of 1.9
The equity is down by 2% since the previous quarter
The revenue has increased by 22% year-on-year and by 6% since the previous quarter
The P/S is 17% above the last 4 quarters average of 0.3 but 13% below the 5-year quarterly average of 0.4

Efficiency

How efficient is Humana business performance
The company's return on assets fell by 12% YoY and by 4.2% QoQ
The return on sales has declined by 11% year-on-year
Humana's return on invested capital has increased by 11% YoY and by 8% QoQ
The return on equity has declined by 8% year-on-year and by 2.9% since the previous quarter

Dividends

What is HUM's dividend history
Dividend details
DPS
$3.54
Dividend yield
0.8%
Payout ratio
34.1%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Humana financials performed over time
Humana's total assets is 49% more than its total liabilities
The quick ratio has decreased by 24% YoY and by 10% from the previous quarter
HUM's total liabilities is up by 23% year-on-year
HUM's debt is 32% smaller than its equity
HUM's debt is down by 12% since the previous quarter
Humana's debt to equity has decreased by 11% QoQ and by 2.9% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.